Image of spreadsheets on glass table during discussion of strategy

Viking Thera Cmn (NASDAQ:VKTX) shares traded -1.62% down during most recent session to reach at the closing price of $7.9. The stock exchanged hands 1.88 Million shares versus average trading capacity of 3.04 Million shares, yielding a market cap of $577.49 Million. Wall Street analysts covering the stock are projecting that the stock will reach $29.79 within the next 52-weeks. The mean target projections are based on 7 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Viking Thera Cmn (NASDAQ:VKTX) high price target of $43 and with a conservative view have low price target of $16.

B. Riley FBR “Initiates Coverage On” Viking Thera Cmn (NASDAQ:VKTX) in a research note issued to investors on 12/12/18 to Buy with price target of $16.

Additionally on 11/19/18 Raymond James “Upgrades” Viking Thera Cmn (NASDAQ:VKTX) to Strong Buy setting price target at $0 and on 9/19/18 Raymond James “Maintained” the stock to Outperform at $43. Furthermore on 9/18/18 H.C. Wainwright “Maintained” the stock to Buy at $28.

On the other hand the company has Relative Strength Index (RSI 14) of 42.84 along with Average True Range (ATR 14) of 0.48, Consequently Viking Thera Cmn (NASDAQ:VKTX)’s weekly and monthly volatility is 3.84%, 5.53% respectively. The company’s beta value is at 2.93.

In terms of Buy, Sell or Hold recommendations, Viking Thera Cmn (NASDAQ:VKTX) has analysts’ mean recommendation of 1.8. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Viking Thera Cmn (NASDAQ:VKTX)’s minimum EPS for the current quarter is at $-0.12 and can go high up to $-0.09. The consensus mean EPS for the current quarter is at $-0.1 derived from a total of 9 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.14 earnings per share for the same quarter during last year.

Previously Viking Thera Cmn (NASDAQ:VKTX) reported $-0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.12 by $0.01. The company posted an earnings surprise of 8.3%.

Currently Viking Thera Cmn (NASDAQ:VKTX)’s shares owned by insiders are 11%, whereas shares owned by institutional owners are 62.5%. However the six-month change in the insider ownership was recorded -3.17%, as well as three-month change in the institutional ownership was recorded 0.87%.

Viking Thera Cmn (NASDAQ:VKTX)’s trailing twelve month revenues are $0, whereas its price to sales ratio for the same period is 0. Its book value per share for the most recent quarter is $4.93 while its price to book ratio for the same period is 1.6, as for as the company’s cash per share for the most recent quarter is $4.16, however its price to cash per share ratio for the same period is 1.9. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.